My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 361

    1.

    Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?

    Haffner SM, D'Agostino R Jr, Festa A, Bergman RN, Mykkänen L, Karter A, Saad MF, Wagenknecht LE.

    Diabetes Care. 2003 Oct;26(10):2796-803.PMID: 14514582 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study.

    Haffner SM, D'Agostino R Jr, Mykkänen L, Tracy R, Howard B, Rewers M, Selby J, Savage PJ, Saad MF.

    Diabetes Care. 1999 Apr;22(4):562-8.PMID: 10189532 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.

    Festa A, D'Agostino R Jr, Hanley AJ, Karter AJ, Saad MF, Haffner SM.

    Diabetes. 2004 Jun;53(6):1549-55.PMID: 15161760 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    [Predictors of abnormal glucose tolerance in persons at risk of type 2 diabetes: the RIAD study]

    Henkel E, Köhler C, Temelkova-Kurktschiev T, Hanefeld M.

    Dtsch Med Wochenschr. 2002 May 3;127(18):953-7. German. PMID: 11987015 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.

    Osei K, Gaillard T, Schuster DP.

    Diabetes Care. 1997 Mar;20(3):396-404.PMID: 9051394 [PubMed - indexed for MEDLINE]Related articles

    6.

    Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention.

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    Diabetes Care. 2004 Jun;27(6):1439-46.PMID: 15161801 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.

    Hanley AJ, Festa A, D'Agostino RB Jr, Wagenknecht LE, Savage PJ, Tracy RP, Saad MF, Haffner SM.

    Diabetes. 2004 Jul;53(7):1773-81.PMID: 15220201 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

    Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study.

    Diabetes. 2002 Apr;51(4):1131-7.PMID: 11916936 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [A study of the degrees of insulin resistance and first-phase insulin secretion of beta-cells in metabolic syndrome patients with different glucose tolerance]

    Hong J, Gu WQ, Zhang YF, Guo Y, Chen HM, Zhang LZ, Zhao YJ, Ning G.

    Zhonghua Yi Xue Za Zhi. 2003 Nov 25;83(22):1952-6. Chinese. PMID: 14703429 [PubMed - indexed for MEDLINE]Related articles

    10.

    Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

    Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T; Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

    Diabetes Care. 2003 Mar;26(3):868-74.PMID: 12610051 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study.

    Haffner SM, Howard G, Mayer E, Bergman RN, Savage PJ, Rewers M, Mykkänen L, Karter AJ, Hamman R, Saad MF.

    Diabetes. 1997 Jan;46(1):63-9.PMID: 8971083 [PubMed - indexed for MEDLINE]Related articles

    12.

    Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.

    Meis SB, Schuster D, Gaillard T, Osei K.

    Ethn Dis. 2006 Autumn;16(4):830-6.PMID: 17061734 [PubMed - indexed for MEDLINE]Related articles

    13.

    Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.

    Viswanathan V, Clementina M, Nair BM, Satyavani K.

    J Assoc Physicians India. 2007 Dec;55:833-7.PMID: 18405128 [PubMed - indexed for MEDLINE]Related articles

    14.

    Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

    Mori Y, Hoshino K, Yokota K, Yokose T, Tajima N.

    Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):334-9.PMID: 15977101 [PubMed - indexed for MEDLINE]Related articles

    15.

    Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance.

    Dzienis-Straczkowska S, Straczkowski M, Szelachowska M, Stepien A, Kowalska I, Kinalska I.

    Diabetes Care. 2003 Mar;26(3):875-80.PMID: 12610052 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study.

    Nóvoa FJ, Boronat M, Saavedra P, Díaz-Cremades JM, Varillas VF, La Roche F, Alberiche MP, Carrillo A.

    Diabetes Care. 2005 Oct;28(10):2388-93.PMID: 16186268 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward?

    Wong MS, Gu K, Heng D, Chew SK, Chew LS, Tai ES.

    Diabetes Care. 2003 Nov;26(11):3024-30.PMID: 14578234 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects.

    Guerrero-Romero F, Rodríguez-Morán M.

    Diabetes Metab. 2003 Feb;29(1):65-71.PMID: 12629450 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population.

    Gupta A, Gupta R, Sarna M, Rastogi S, Gupta VP, Kothari K.

    Diabetes Res Clin Pract. 2003 Jul;61(1):69-76.PMID: 12849925 [PubMed - indexed for MEDLINE]Related articles

    20.

    Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.

    Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu D, Freed MI, Herman WH, Holman RR, Jones NP, Lachin JM, Viberti GC; ADOPT Study Group.

    Diabetes. 2006 Aug;55(8):2357-64.PMID: 16873701 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity